Patent · US Active

Polynucleotides encoding ketoreductases for producing stereoisomerically pure statins and synthetic intermediates therefor

US8617864B2 · kind B2 · utility

0Cited by
33References
7Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 9, 2012
Grant dateDec 31, 2013
Priority date
Expiry dateAug 9, 2032

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12P7/62
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

The present disclosure provides ketoreductase enzymes having improved properties as compared to a naturally occurring wild-type ketoreductase enzyme. Also provided are polynucleotides encoding the engineered ketoreductase enzymes, host cells capable of expressing the engineered ketoreductase enzymes, method of using the engineered ketoreductase enzymes to synthesize a variety of chirally pure compounds, and the chirally pure compounds prepared therewith.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.